Info

NuGEN uniquely enables researchers to perform robust, high-fidelity expression analysis from limited and highly compromised clinical specimens. These solutions help researchers unlock discoveries in previously inaccessible samples such as formalin-fixed paraffin-embedded (FFPE), laser-captured, micro-dissected tissue (LCM), and others. Founded in 2000, NuGEN Technologies, Inc. is privately held and headquartered in San Carlos, California near the heart of Silicon Valley. The company has commercialized numerous proprietary RNA amplification and labeling technologies and products for discovery and clinical research applications.